A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
Clinical trial NCT03575793 · COMPLETED
Trial details
- NCT number
- NCT03575793
- Sponsor
- Salma Sabbour
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-06
- Primary completion
- 2023-09-25
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.